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Changes in mitochondrial function in a variety of cells/tissues are critical for orches-
trating systemic energy homeostasis and are linked to the development of obesity 










cellular	 metabolic	 flexibility,	 these	 animals	 may	 have	 alterations	 in	 their	 systemic	
response	 to	 altered	 energy	 availability,	 either	 nutritional	 excess	 or	 insufficiency.	








change the physiological response to deviations in systemic energy availability at the 
whole organism level.
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1  | INTRODUC TION
Mitochondrial function is critical for regulating both cellular and sys-
temic	 energy	 homeostasis,	 with	 mitochondrial	 dysfunction	 within	
metabolic tissues being a key feature of obesity and many of its 
comorbidities.1- 3 The mitochondrial translocator protein of 18 kDa 
(TSPO)	resides	in	the	outer	mitochondrial	membrane	and	contributes	
to	 a	 range	 of	 mitochondrial	 processes,	 including	 cellular	 metabo-
lism,	 cholesterol	 transport	 and	 reactive	oxygen	 species	 (ROS)	pro-
duction.4	For	example,	transfection	of	Tspo	 into	Jurkat	lymphocyte	
T-	cells,	which	ordinarily	do	not	express	TSPO,	enhances	ATP	produc-
tion compared to wild- type T- cells.5	Knockout	of	Tspo	in	Leydig	MA-	





tion including cellular energetics and substrate utilisation.
TSPO	is	expressed	at	varying	levels	throughout	the	body.9 It is 
highly	 enriched	 in	 metabolic	 tissues,	 including	 adipose	 tissue13-	15 
and	the	 liver,16,17 as well as steroidogenic organs where it is impli-
cated in steroid hormone production18,19; although the necessity of 
TSPO	 for	 steroidogenesis	 is	 debated.20	 TSPO	 is	 also	 found	within	
the	brain,	primarily	within	glia,21-	24 although there are also reported 
regional instances of neuronal localisation.25,26	TSPO	expression	is	
altered by obesity in a tissue- dependent manner.13,27,28	For	example,	
previous work by our group showed reduced Tspo	gene	expression	
and	binding	of	the	TSPO	ligand	PK11195	in	both	white	and	brown	
adipose tissue from obese mice (both diet- induced obese and me-
lanocortin-	4	receptor	deficient13).	 Immunohistochemical	data	from	
this	 study	 suggested	 that,	within	 adipose	 tissue	of	obese	 animals,	
TSPO	 levels	may	be	decreased	 in	 adipocytes	but	 increased	 in	 ad-
ipose	 tissue	macrophages	within	 “crown-	like”	 structures,29	 which,	
during	 obesity,	 are	 predominantly	 of	 a	 pro-	inflammatory	 pheno-
type.30	This	differential	pattern	of	TSPO	expression	may	correlate	
with differences in mitochondrial function within these cell types 
during	 obesity,	 with	 adipocytes	 from	 obese	 animals	 showing	 mi-
tochondrial	 dysfunction	 and	 decreased	 FAO,	 whereas	 the	 pro-	
inflammatory adipose macrophages are in a highly glycolytic state.31 
Taken	together,	these	data	suggest	that	TSPO	may	play	a	role	in	the	
pathophysiological response to obesity through modulation of mi-
tochondrial	 activity,	 and	 that	 loss	of	 this	protein	could	 impact	 the	
development of obesity and associated pro- inflammatory changes 





type	 controls.	 In	 a	 separate	 global	 germline,	 TSPO	 knockout	 line,	
female but not male mice had a modest but statistically significant 
increase	 in	body	weight,	 from	1	 to	5	weeks	of	 age,	 although	data	
were not reported from older animals.18	Other	global	germline	TSPO	
knockout mouse lines have also been generated and shown to be 
viable,	although	these	studies	did	not	report	growth	rates	or	body	
weight data.33,34
Combined data from the in vitro metabolism studies suggests 
that	 TSPO	 may	 contribute	 to	 the	 regulation	 of	 cellular	 substrate	
utilisation,	 which	 is	 important	 for	 the	 physiological	 adaptation	 to	
changes in energy availability.5,7	In	the	present	study,	we	tested	the	
hypothesis	that	global	TSPO	knockout	mice	will	respond	differently	
to deviations in energy availability than their wild- type littermates. 
We	utilised	overnight	 fasting	 followed	by	 re-	feeding	 to	assess	 the	















The allele construct to knockout Tspo was generated at the 
Wellcome	 Trust	 Sanger	 Institute	 (Hinxton,	 UK)	 as	 part	 of	 the	
International	 Mouse	 Knockout	 Consortium.	 Exons	 2	 and	 3	 of	
the Tspo	 gene	 were	 labelled	 by	 a	 LacZ	 and	 a	 neomycin	 cassette	
flanked	by	LoxP	sites.	Following	a	cross	with	alleles	expressing	cre-	
recombinase,	a	knockout	of	the	neomycin	cassette	and	exons	2	and	3	












and	 randomised	 to	 a	 unique	 ID	by	 animal	 care	 technicians	 before	
being individually housed. The investigators were blinded to the 
genetic	identity	of	the	mice	throughout	the	study.	All	animals	were	
housed under a 12:12 hour light/dark photocycle (lights on 7.00 am)	
at 22 ±	2°C	and	55%	±	2%	humidity.	Unless	stated	otherwise,	an-
imals	 had	 ad	 libitum	access	 to	 standard	 laboratory	 chow	 (LabDiet	
[EU]	 Rodent	 diet	 5LF2;	 LabDiet,	 St	 Louis,	 MO,	 USA)	 and	 water.	
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Weekly	measurements	 of	 standard	 chow	 intake	 and	 body	weight	
were	collected	on	Monday	afternoons	 for	12	weeks	 (Figure	1).	To	
minimise	 individual	housing	time,	all	animals	were	studied	simulta-
neously with the age of the mice ranging between 7 and 10 weeks 
at week 1 of study.
In	total,	12	male	TSPO+/+,	14	male	TSPO−/−,	13	female	TSPO+/+ 
and	 14	 female	 TSPO−/− mice were studied. This does not include 
three	 animals	 that	 started	 the	 study	 but	were	 excluded	 from	 the	
statistical analysis and results reporting: one animal was revealed 
as	heterozygous	following	the	confirmatory	genotype	analysis,	and	
two wild- type animals were killed before the study was complete as 
a result of welfare concerns associated with failure to thrive/runting. 
The investigators were blinded to the genotype of the animals until 
all	measurements,	including	image	analysis,	were	complete.
2.2 | Genotyping
The genetic identity of the mice was confirmed by polymerase chain 
reaction testing on liver samples taken from the mice following 
death at the end of the study. To detect the wild- type Tspo	allele,	a	
5′	arm	primer	sequence	of	AGCAGAAGTAGGAAGAAGGTG	and	a	3′	
arm	sequence	of	GTCAACCCATCACTGCCTTCA	were	used.	To	de-
tect the truncated mutant Tspo	allele	present	in	the	knockout	mice,	
a	 LAR3	 primer	 sequence	 of	 CAACGGGTTCTTCTGTTAGTCC	 was	
used	in	addition	to	the	3′	arm	primer.
2.3 | Fast- induced re- feeding
After	5	weeks	of	acclimatisation	and	monitoring	of	food	intake	and	
body	 weight	 (Figure	 1),	 the	 homeostatic	 response	 of	 the	mice	 to	
food deprivation was tested. This procedure was performed in the 
holding	room	in	which	the	mice	were	kept.	Within	30	minutes	prior	
to lights out (7.00 pm),	standard	chow	was	removed	from	the	cages	
and	the	body	weight	of	each	animal	was	recorded.	After	12	hours,	










body	 weight	 were	 continued	 with	 measurements	 of	 HFD	 intake	
made	 three	 times	 a	 week	 (Monday,	Wednesday	 and	 Friday	 after-
noons)	 (Figure	1).	 The	 cage	 floors	were	 checked	 for	 residual	 food	




2.5 | Intraperitoneal glucose tolerance test
At	lights	on	(7.00	am),	eight	male	TSPO+/+,	eight	male	TSPO−/−,	nine	
female	 TSPO+/+	 and	 eight	 female	 TSPO−/− mice were moved to a 
procedure room and their food removed. To ensure representative 
sampling,	 animals	 of	 each	 genotype	 were	 randomly	 selected	 for	





were killed the following week






Biosensor,	 Suwon-	si,	 South	Korea).	 The	mice	 then	 received	 an	 i.p.	




120 minutes. This test was performed twice on the same mice during 
the	study:	once	at	9-	10	weeks	(prior	to	the	introduction	of	the	HFD)	
and	again	after	5	weeks	of	a	HFD	 (Figure	1).	Only	a	subset	of	 the	
total cohort of animals were used for glucose tolerance test studies 
because,	after	completing	initial	studies,	there	was	no	observable	ef-
fect,	and	so	we	could	not	support	exposing	animals	to	an	unneces-
sary procedure that was not supported by the data.
2.6 | Tissue collection
After	5	weeks	of	a	HFD	(Figure	1),	the	mice	were	killed	by	an	over-
dose of pentobarbitone sodium (1.6 g kg- 1; 100 μL	i.p.)	followed	by	
decapitation.	 Whole	 liver	 and	 peri-	gonadal	 white	 adipose	 tissue	
(WAT)	from	all	mice	were	dissected,	washed	briefly	in	0.01	mol	L- 1 





2.7 | Histological processing of liver tissue
A	 random	 subset	 of	 liver	 samples	 (six	 male	 TSPO+/+,	 seven	 male	
TSPO−/−,	 seven	 female	TSPO+/+,	 six	 female	TSPO−/−)	were	paraffin	
embedded	by	the	Histopathology	laboratory	at	the	Royal	Devon	&	
Exeter	Hospital	 (Exeter,	UK).	 The	 paraffin-	embedded	 blocks	were	
sliced	 using	 a	 rotary	 microtome	 into	 sections	 that	 were	 5	 μm in 
width	and	floated	from	a	heat	bath	to	Superfrost™	(Thermo	Fisher	
Scientific,	 Waltham,	 MA,	 USA)	 charged	 glass	 microscope	 slides.	
The	slides	were	left	overnight	to	air-	dry,	then	deparaffinised	in	two	













mounting	 medium	 (06522;	 Sigma-	Aldrich).	 The	 mounting	 medium	
was	left	to	dry,	and	the	slides	were	then	imaged	using	light	micros-
copy	(DFC340	FX;	Leica,	Wetzlar,	Germany).






T)	 (BP151-	00;	 Thermo	 Fisher	 Scientific)	 for	 1	 hour	 at	 room	 tem-








Abcam)	 (diluted	 1:250	 in	 PBS-	T	 containing	 20%	NDS)	 for	 1	 hour	




ture.	The	 tissue	was	washed	 for	 a	 further	10	minutes	 in	PBS	be-
fore	 incubation	 in	 1:1000	 4′,6-	diamidino-	2-	phenylindole	 (D1306;	
Thermo	Fisher	Scientific)	diluted	in	PBS.	Tissue	was	mounted	onto	
glass	slides,	excess	liquid	was	dried	by	wicking	away	with	tissue	and	




Three random images per liver sample were captured using standard 
light	microscopy.	Using	FIJI	ImageJ,	version	1.52i	(National	Institutes	
of	Health,	Bethesda,	MD,	USA),	images	were	converted	to	8-	bit	in-
verted black- and- white representations of the tissue structure and 
the	‘Analyse	particles’	feature	of	ImageJ	was	applied.	This	provided	
information	 including	 the	mean	area	of	black	particles,	which	cor-
responded to the size of vacuolarised sites in the liver tissue. The 
mean for each of the three images taken per animal and plotted 
accordingly.
WAT	structure	was	imaged	at	20× magnification using a confocal 
microscope	and	6	Z-	stacks	were	collated	per	section,	one	section	per	
animal.	 The	 area	 of	 each	 adipocyte	 and	number	 of	 F4/80-	postive	
macrophages	was	measured	in	one	random	WAT	image	per	animal	
using	ImageJ	and	plotted	accordingly.





CA,	USA).	Data	 are	presented	 as	 the	 individual	 points	per	 animal,	
where	possible,	with	error	bars	indicating	the	SEM.	Data	were	tested	
for normal distribution and parametric or non- parametric statistical 
tests	were	applied,	as	appropriate.	P <	0.05	was	considered	statisti-
cally	signiifcant.	For	HFD	intake	in	female	mice,	as	a	result	of	food	




3.1 | Germline global deletion of TSPO did not 
affect growth curves or food intake of the mice 
maintained on standard diet in the absence of a 
homeostatic challenge
As	anticipated,	based	on	a	previous	report	using	an	independently	
generated	mouse	 line,9 there was no difference in growth curves 
between	the	TSPO+/+	and	TSPO−/− genotypes in both male (Fgenotype 
1,24 =	 1.354,	 P =	 0.256,	 repeated	 measures	 mixed-	effect	 model)	
(Figure	2A)	and	female	mice	(Fgenotype = 1,25 =	0.854,	P =	0.364,	re-
peated	 measures	 mixed-	effect	 model)	 (Figure	 2B)	 maintained	 on	
standard	chow.	As	expected,	in	both	sexes,	there	was	an	influence	
of	experimental	period	on	growth	(Ftime 1.9,45.7 =	399.1,	P < 0.0001 
[males]	 [Figure	 2A],	 repeated	 measures	 mixed-	effect	 model;	
Ftime 2,50 =	173,	P <	0.0001	 [females]	 [Figure	2B],	 repeated	meas-
ures	 two-	way	 ANOVA).	 In	 the	male	 cohort	 in	 the	 growth	 curves,	
there was a statistically significant interaction between genotype 
and	experimental	period	(Finteraction	11,263 =	1.93,	P =	0.036,	repeated	
measures	mixed-	effect	model)	(Figure	2A),	although	Sidak's	multiple	
comparisons test did not identify any statistically significant differ-
ences at any individual time point. There was no interaction between 
genotype	and	experimental	period	 in	the	growth	curves	of	 female	
mouse cohort (Finteraction 11,275 =	0.912,	P =	0.529,	repeated	measures	
two-	way	ANOVA)	(Figure	2B).
There were no effects of genotype on weekly food intake 
in the male mice (Fgenotype	 1,24 =	 1.066,	P =	 0.312,	 repeated	mea-
sures	 mixed-	effect	 model)	 (Figure	 2C),	 nor	 in	 the	 female	 cohort	
(Fgenotype	 1,25 =	 0.762,	P =	 0.391,	 repeated	measures	mixed-	effect	
model)	 (Figure	2D).	 In	 both	 sexes,	 there	was	 a	 statistically	 signifi-
cant	influence	of	experimental	time	on	intake	(Ftime 5.5,131.4 =	10.01,	
P <	 0.0001	 [males]	 [Figure	 2C];	Ftime 5.6,139.7 =	 10.55,	P < 0.0001 
[females]	 [Figure	 2D],	 both	 analysed	 using	 repeated	 measures	
mixed-	effect	 model)	 but	 no	 interaction	 between	 time	 and	 gen-
otype (Finteraction	 10,239 =	 0.675,	 P =	 0.747	 [males]	 [Figure	 2C];	
Finteraction	10,249 =	0.370,	P =	0.959	[females]	[Figure	2D],	both	ana-
lysed	using	repeated	measures	mixed-	effect	model).	Similarly,	there	
was an effect of time but not genotype on cumulative food intake 
in the male (Ftime 1.099,25.60 =	7198,	P < 0.0001; Fgenotype	1,24 =	1.15,	
P =	 0.29,	 repeated	measures	mixed-	effect	model)	 (Figure	 2E)	 and	
female mice (Ftime 1.036,25.71 =	6214,	P < 0.0001; Fgenotype	1,25 =	0.817,	
P =	0.37,	repeated	measures	mixed-	effect	model)	(Figure	2F).	There	




3.2 | Germline global deletion of TSPO did not 





two measurements: day- time compensatory food intake during 
the	 24-	hour	 re-	feeding	 period	 following	 a	 12-	hour	 overnight	 fast,	
and the body weight changes in response to fasting and re- feeding. 
These measures reflect the physiological response to food depriva-
tresuion,	and	homeostatic	compensation	during	re-	feeding:	the	abil-
ity of the animals to sense and recover body mass after a state of 
negative energy balance.
In	male	mice,	as	expected,	there	was	a	significant	effect	of	en-
ergy state on body weight (Fenergy state 1.05,25.29=	52.44,	P <	0.0001,	
repeated	measures	two-	way	ANOVA)	(Figure	3A).	No	effect	of	gen-
otype on body weight before and after food deprivation or after 
re- feeding was observed (Fgenotype	1,24 =	1.28,	P =	0.269,	 repeated	
measures	 two-	way	 ANOVA)	 (Figure	 3A),	 nor	 was	 there	 an	 inter-
action between energy state and genotype (Finteraction	 2,48 =	 1.56,	
P =	 0.22,	 repeated	 measures	 two-	way	 ANOVA)	 (Figure	 3A).	 As	
expected,	 there	 was	 a	 statistically	 significant	 effect	 of	 time	 on	
food intake during the fast- induced re- feeding phase in male mice 
(Ftime 1.99,47.63 =	 2232,	 P <	 0.001,	 repeated	 measures	 two-	way	
ANOVA)	 (Figure	 3B),	 although	 no	 impact	 of	 genotype	 was	 ob-
served (Fgenotype	1,24 =	0.002,	P =	0.963,	repeated	measures	two-	way	
ANOVA)	 (Figure	 3B),	 nor	 was	 there	 an	 interaction	 between	 time	
and genotype (Finteraction	4,96 =	0.14,	P =	0.965,	 repeated	measures	
two-	way	ANOVA)	 (Figure	3B).	Similarly,	 in	 female	mice,	 there	was	
a statistically significant effect of energy state on body weight 
(Fenergy state 1.8,44.93 =	 609.2,	P <	 0.0001,	 repeated	measures	 two-	
way	 ANOVA)	 (Figure	 3C),	 although	 there	 was	 no	 effect	 of	 geno-
type (Fgenotype	1,25 =	 0.93,	P =	 0.345,	 repeated	measures	 two-	way	
ANOVA)	 (Figure	3C)	and	no	 interaction	between	energy	state	and	
genotype (Finteraction	2,50 =	0.25,	P =	0.781,	repeated	measures	two-	
way	ANOVA)	(Figure	3C).	Again,	in	female	mice,	there	was	a	statis-
tically significant effect of time on cumulative compensatory food 
intake during re- feeding (Ftime 2.29,57.14 =	1686,	P <	0.0001,	repeated	
measures	 two-	way	 ANOVA)	 (Figure	 3D),	 although	 there	 was	 no	
statistically significant effect of genotype on food intake during re- 
feeding (Fgenotype	1,25 =	3.05,	P =	0.093,	repeated	measures	two-	way	
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ANOVA)	 (Figure	 3D)	 and	 no	 interaction	 between	 time	 and	 geno-
type (Finteraction	4,100 =	1.23,	P =	0.304,	repeated	measures	two-	way	
ANOVA)	(Figure	3D).
3.3 | Germline global knockout of TSPO 
provided no protection against diet- induced weight- 
gain after 5 weeks of a HFD
Absence	 of	 TSPO	 had	 no	 effect	 on	 high-	fat	 diet-	induced	 body	
weight gain in male (Fgenotype	 1,24 =	 0.36,	 P =	 0.55,	 repeated	
measures	 two-	way	 ANOVA)	 (Figure	 4A)	 or	 female	mice	 (Fgenotype 
1,25 =	 2.44,	 P =	 0.131,	 repeated	 measures	 two-	way	 ANOVA)	
(Figure	4B).	As	anticipated,	experimental	time	period	had	a	signifi-
cant	 influence	on	weight	gain	 in	both	sexes	 (Ftime 1.95,46.7 =	291.4,	







intake (Fgenotype	1,24 =	0.988,	P =	0.330	[males]	[Figure	4C],	repeated	
measures	two-	way	ANOVA;	Fgenotype	1,25 =	2.02,	P =	0.167	[females]	
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[Figure	 4D],	 repeated	 measures	 mixed-	effects	 analysis),	 whereas	
the	experimental	time	period	did	(Ftime 1.75,41.97 =	99.31,	P < 0.0001 
[males]	 [Figure	 4C],	 repeated	 measures	 two-	way	 ANOVA;	
Ftime 2.78,62.64 =	61.80,	P <	0.0001	[females]	 [Figure	4D],	repeated	
measures	mixed-	effects	analysis),	although	there	was	no	interaction	
of	 genotype	 and	experimental	 time	period	 (Finteraction	4,96 =	 0.167,	
P =	0.957	[males]	[Figure	4C],	repeated	measures	two-	way	ANOVA;	
Finteraction	 7,158 =	 0.368,	 P =	 0.92	 [females]	 [Figure	 4D],	 repeated	
measures	mixed-	effects	analysis).	The	calorie	intake	in	the	female	





of genotype because there were five data points removed from the 
TSPO−/−	group	and	four	from	TSPO+/+ group.
F I G U R E  3  Germline	global	deletion	TSPO	had	no	impact	on	the	homeostatic	response	to	fasting	and	re-	feeding	in	either	male	or	
female mice. Mice had food removed at 7.00 pm and were fasted overnight for 12 hours before having their standard chow diet returned 
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TA B L E  1  Summary	of	the	results	of	statistical	analyses	(three-	way	ANOVA)	of	the	relationships	between	genotype,	sex	and	diet	on	body	
weight,	basal	blood	glucose	and	area	under	the	curve	(AUC)	of	glucose	clearance	in	the	glucose	tolerance	test
Body weight (g) Basal blood glucose (mmol L- 1) AUC
Diet F 1,97 = 205.7, P < 0.0001 F 1,51 = 27.79, P < 0.0001 F 1,51 = 65.71, P < 0.0001
Sex F 1,97 = 48.22, P < 0.0001 F 1,51 = 4.88, P = 0.032 F 1,51 = 13.28, P = 0.0006
Genotype F	1,97 =	0.29,	P =	0.59 F	1,51 =	0.40,	P =	0.53 F	1,51 =	0.024,	P = 0.88
Diet ×	Sex F	1,97 =	0.29,	P =	0.59 F 1,51 = 5.11, P = 0.028 F	1,51 =	0.051,	P = 0.83
Diet ×	Genotype F	1,97 =	0.93,	P =	0.34 F	1,51 =	0.40,	P =	0.53 F	1,51 =	0.11,	P =	0.75
Sex	×	Genotype F 1,97 = 4.52, P = 0.036 F	1,51 =	1.91,	P = 0.17 F	1,51 =	1.29,	P = 0.26
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In	the	analysis	of	the	body	weight	data,	when	considering	the	
relationships	 of	 all	 three	 independent	 variables	 (diet,	 sex,	 geno-
type)	together	using	a	three-	way	ANOVA,	there	were	statistically	






3.4 | There was no effect of germline global 
deletion of TSPO on glucose tolerance in either mice 
fed standard chow or a HFD
Intraperitoneal glucose tolerance tests were conducted at weeks 
9-	10	of	 the	study	 (Figure	1)	 to	establish	whether	 there	was	an	ef-
fect	of	loss	of	TSPO	on	glucose	homeostasis	in	animals	fed	standard	
chow.	 This	was	 then	 repeated	 at	week	 17	 of	 the	 study,	 following	
5	weeks	of	 exposure	 to	 the	high-	fat	 diet	 to	 assess	whether	 there	
was a genotype- dependent effect of diet on glucose homeosta-
sis.	 In	 standard	 chow	 fed	 animals,	 there	 was	 no	 statistically	 sig-
nificant	 impact	 of	 sex	 or	 genotype	 on	 basal	 blood	 glucose	 levels	
(Fsex	1,29 =	0.00145,	P =	0.970;	Fgenotype	1,29 =	0.870,	P =	0.359,	two-	
way	ANOVA)	(Figure	5A).	However,	there	was	a	statistically	signifi-
cant interaction between the two variables (Finteraction	1,29 =	5.839,	
P =	0.222,	two-	way	ANOVA)	(Figure	5A)	and	Sidak's	multiple	com-
parisons test indicated that the effect in males was approaching 
statistical significance (P =	 0.0526),	 whereas	 there	 was	 no	 effect	
in females (P =	0.5044).	Within	sex,	 there	was	no	effect	of	geno-
type on glucose clearance during the glucose tolerance test in the 
mice (Fgenotype	1,14 =	0.0037,	P =	0.952	[males];	Fgenotype	1,15 =	0.064,	
P =	0.803	[females],	both	analysed	using	a	repeated	measures	two-	
way	ANOVA)	(Figure	5B).
After	 a	 HFD,	 there	 was	 an	 impact	 of	 sex	 but	 not	 genotype	
on basal blood glucose with female mice having a significantly 
lower level (Fsex	 1,22 =	 9.40,	 P = 0.006; Fgenotype	 1,22 = 2.011e
- 32,	
P >	 0.99;	Finteraction	 1,22 =	 0.119,	P =	 0.734,	 both	 analysed	 using	 a	
two-	way	ANOVA)	 (Figure	5D).	 In	 the	glucose	tolerance	test,	 there	
was	no	 effect	 of	 genotype	on	 glucose	 clearance	 in	HFD	 fed	mice	
of	 either	 sex	 (Fgenotype	1,11 =	 1.290,	P =	 0.280	 [males]	 [Figure	5E];	
Fgenotype	1,11 =	0.429,	P =	0.526	[females]	[Figure	5F],	both	analysed	
using	a	repeated	measures	two-	way	ANOVA).
When	 considering	 the	 relationships	 of	 all	 three	 indepen-
dent	 variables	 (diet,	 sex,	 genotype)	 together	 using	 a	 three-	way	
ANOVA,	there	were	statistically	significant	effects	of	diet	alone	
and	 sex	 alone	 on	 both	 basal	 blood	 glucose	 and	 area	 under	 the	
curve	 (AUC)	of	glucose	clearance	 in	a	glucose	 tolerance	 test.	 In	
the	case	of	basal	blood	glucose,	there	was	also	a	statistically	sig-
nificant	 interaction	between	diet	and	sex,	with	 the	 female	mice	
showing a comparatively lower increase in basal blood glucose 
after	5	weeks	of	a	HFD	than	the	male	animals.	These	analyses	are	
summarised in Table 1.
3.5 | Germline global deletion of TSPO did not 
result in changes to liver nor peri- gonadal adipose 
tissue composition in mice fed a HFD
Germline	 line	global	TSPO	deletion	did	not	affect	 the	 liver	weight	
from the female or male mice (Fgenotype	 1,48 =	 0.009,	 P =	 0.926,	
two-	way	ANOVA)	 (Figure	6A),	 nor	 the	 liver	weight	 as	proportion-
ate to body weight (Fgenotype	1,48 =	0.07,	P =	0.8,	two-	way	ANOVA)	
(Figure	6B).	As	might	be	expected	based	on	the	differences	in	body	
weight,	there	was	a	statistically	significant	influence	of	sex	on	liver	
weight (Fsex	1,48 =	24.92,	P <	0.0001,	two-	way	ANOVA)	(Figure	6A).	
Liver	weight	as	a	proportion	of	body	weight	was	also	influenced	by	
sex	(Fsex	1,48 =	18.23,	P <	0.0001,	two-	way	ANOVA)	(Figure	6B),	al-
though	 there	was	no	 interaction	between	genotype	and	sex	 in	ei-




in	male	and	female	TSPO+/+	and	TSPO−/− mice indicated no effect of 
genotype (Fgenotype	1,22 =	0.17,	P =	0.69,	two-	way	ANOVA)	(Figure	6C)	
or	sex	(Fsex	1,22 =	0.16,	P =	0.69,	two-	way	ANOVA)	(Figure	6C),	nor	an	
interaction between the two (Finteraction	1,22 =	0.852,	P =	0.366,	two-	
way	ANOVA)	(Figure	6C).	Representative	images	of	the	liver	histol-








cohorts,	 nor	 on	 the	 weight	 of	 peri-	gonadal	WAT	 as	 a	 proportion	
of body weight (male cohort P =	0.824,	unpaired	t test; female co-
hort =	0.395,	Mann-	Whitney	U	test)	(Figure	7B).	Absence	of	TSPO	
did not influence mean adipocyte size in either male (P =	0.749,	un-
paired t	test)	or	female	mice	(P =	0.687,	unpaired	t	test).	There	was	
no	difference	 in	 the	number	of	F4/80-	positive	macrophages	 iden-
tified	 in	WAT	 between	 TSPO+/+	 and	 TSPO−/− animals in both the 
males (P =	0.618,	Mann-	Whitney	U	test)	and	females	(P =	0.175,	un-
paired t	test).	As	expected,	TSPO	immunoreactivity	was	expressed	
throughout	 TSPO+/+	 tissue	 in	 both	 male	 (Figure	 7Eiii)	 and	 female	
mice	 (Figure	7Giii)	and	absent	 in	WAT	from	male	 (Figure	7Fiii)	and	
female	 (Figure	7Hiii)	TSPO−/−	mice.	For	WAT	analyses,	direct	com-
parison	between	sexes	was	not	used	here	as	a	result	of	the	different	




In a genetically modified mouse line generated independently 
from	 the	 one	 presented	 here,	 previous	 research	 has	 examined	
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the	 impact	 of	 global	 germline	 loss	 of	 TSPO	 in	 mice	 on	 normal	
growth.9,18	Critically,	for	our	hypothesis,	the	potential	differences	
in the physiological response to alterations in energy availability in 
these	animals	were	not	explored.	Based	on	published	data	indicat-
ing	 regulation	 of	 TSPO	 expression	 in	 rodents	 by	 obesity13 and a 
role	 for	TSPO	 in	modulation	of	mitochondrial	 function,4-	8 we hy-
pothesised that germline deletion of the Tspo gene in mice could 
impact the adaptive physiological response to alterations in energy 
availability.
Using	the	Tspotm1b(EUCOMM)Wtsi	mouse	line,	we	found	that	germ-
line	 global	 loss	 of	 TSPO	did	 not	 impact	 growth	 curves	 of	male	 or	
female mice maintained on standard laboratory chow. This inde-
pendently	confirms	the	findings	of	Banati	et	al,9 and complements 
their study with measurements of weekly food intake. In the present 
study,	animals	with	germline	global	loss	of	TSPO	did	not	show	any	
differences in their body weight or food intake in the negative (fast- 
induced	re-	feeding)	or	positive	(5	weeks	of	a	HFD)	energy	availabil-








tentially appeared to be moving towards divergence in female mice 
towards	the	end	of	our	study.	Indeed,	three-	way	ANOVA	analysis	of	
the	body	weight	a	data	(comparing	before	and	after	HFD)	revealed	
a	 statistically	 significant	 interaction	 between	 sex	 and	 genotype	
(sex	×	genotype),	but	not	diet,	sex	and	genotype	(diet	×	sex	× geno-
type).	Unfortunately,	limitations	in	our	ethical	approvals	meant	that	




homeostasis	 in	 the	mice	 that	were	 studied,	 as	 indicated	by	 an	 in-
creased	AUC	in	the	glucose	tolerance	test,	although	this	was	seen	
in	all	animals	regardless	of	genotype.	Similarly,	within	sex,	we	saw	
F I G U R E  5  Germline	deletion	of	TSPO	had	no	impact	on	basal	blood	glucose	or	glucose	clearance	in	a	glucose	tolerance	test.	TSPO+/+ 
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no difference in gross weight or morphology of two key metabolic 





mediated	global	TSPO	knockout)	 results	 in	neutral	 lipid	accumula-
tion	 in	 the	 gonads,	 adrenal	 glands	 and	 liver34; although there has 
been some debate regarding whether these animals truly represent 
a	global	TSPO	deficient	model.35	However,	in	the	present	study,	no	
genotype-	dependent	 differences	 in	WAT	and	 liver	were	observed	
in	the	HFD-	fed	animals,	correlating	with	the	results	of	the	glucose	
tolerance tests.
Given	 the	 importance	 of	 mitochondrial	 function	 for	 survival,	
it is possible that developmental adaptations following germline 
deletion	may	 functionally	 compensate	 for	 systemic	 loss	 of	 TSPO.	
Published	 studies	 have	 demonstrated	 an	 impact	 of	 tissue-	specific	
loss	of	TSPO	expression	on	growth,	energy	and/or	glucose	homeo-
stasis.24,36	 To	modify	 TSPO	expression	 exclusively	 in	 tanycytes	 in	
the	mouse	brain,	Kim	et	al24 injected a viral vector containing cre- 
recombinase	into	the	third	ventricle	of	6-	week-	old	TSPO	fl/fl	mice,	
resulting	in	knockdown	of	TSPO	in	these	cells.	Loss	of	TSPO	in	tany-
cytes in adult mice conferred relative protection from weight gain 
following	a	HFD,	associated	with	reduced	food	intake	and	changes	
in	energy	expenditure,	but,	surprisingly,	 it	did	not	 improve	glucose	
homeostasis in a glucose or insulin tolerance test.24	An	independent	
F I G U R E  6  There	were	no	differences	in	liver	weight	or	mean	vacuolarised	area	between	high-	fat	fed	TSPO+/+	and	TSPO−/− mice. 
Liver	weight	(A),	liver	weight	normalised	to	body	weight	(B)	and	mean	vacuolarised	area	(C)	(as	a	proxy	for	lipid	accumulation)	in	male	
and	female	TSPO+/+	and	TSPO−/− mice. There were no statistically significant effects of genotype on any of the parameters measured. 
There	was	a	statistically	significant	effect	of	sex	on	liver	weight	(A)	(Fsex	1,48 =	24.92,	P <	0.0001)	and	liver	weight	normalised	to	body	
weight	(B)	(Fsex	1,48 =	18.23,	P <	0.0001).	*P<	0.05,	***P<0.001.	Statistical	analysis	was	performed	using	two-	way	ANOVA	and	Tukey's	
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study	investigated	the	consequences	of	conditional	TSPO	knockout	
from predominantly steroidogenic tissues using the Nr5a1- promotor 
in mice; this resulted in mice with alterations in growth and elevated 
blood	 glucose	 and	 lipids,36 which is postulated to be concomitant 
with alterations in adrenaline levels in this model.19	Pharmacological	
studies	also	support	a	potential	role	for	TSPO	in	regulating	glucose	
and/or	energy	homeostasis,24,37 although these studies have used 
PK11195	which,	at	high	doses,	 reportedly	has	off	 target	effects.38 
Further	 studies	 are	 needed	 with	 newer	 generation	 TSPO	 ligands	
with higher specificity and potency.38
To	conclude,	 the	observations	made	 in	 the	present	 study	 indi-
cate,	 contrary	 to	 our	 hypothesis,	 that	 global	 germline	TSPO	dele-
tion	 in	mice	does	not	affect	body	weight	or	 food	 intake,	 including	
in	response	to	the	alterations	in	energy	availability	examined.	One	
limitation of our study was the reliance on a germline deletion 
model,	 where	 developmental	 compensation/adaptations	 cannot	
be	excluded.	Future	studies	using	adult	inducible	models	and	phar-
macological approaches would be necessary to further test the 
hypothesis.
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